Sbi Securities Co., Ltd. Immunic, Inc. Transaction History

Sbi Securities Co., Ltd.

  • $3.48 Trillion
  • Q2 2025

A detailed history of Sbi Securities Co., Ltd. transactions in Immunic, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 3,605 shares of IMUX stock, worth $2,992. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,605
Previous 3,594 0.31%
Holding current value
$2,992
Previous $3.92 Million 35.82%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
BUY
$0.66 - $1.15 $7 - $12
11 Added 0.31%
3,605 $2.51 Million
Q1 2025

May 01, 2025
BUY
$0.94 - $1.3 $1,301 - $1,800
1,385 Added 62.7%
3,594 $3.92 Million
Q4 2024

Feb 05, 2025
BUY
$1.0 - $1.61 $2,209 - $3,556
2,209 New
2,209 $2.21 Million

Others Institutions Holding IMUX

# of Institutions
63
Shares Held
50M
Call Options Held
13.2K
Put Options Held
60.6K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $25.4M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email